EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Training the microbiota to increase immune checkpoint blockade and to reduce toxicity

Maria Rescigno iD

European Journal of Immunology · 2023

DOI: 10.1002/eji.202250183 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift European Journal of Immunology, 2023. Verfasst von Maria Rescigno. Beteiligte Einrichtung: IRCSS Humanitas Research Hospital, Milan, Italy. Hauptthemen laut MEDLINE: Neoplasms, Microbiota, Probiotics. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 42 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

There is no doubt that immunotherapy, particularly immune checkpoint blockade (ICB), has drastically improved treatment of metastatic cancer patients. Microbiota composition has been proposed to be one of the reasons for failure or success. ICB works via the activation or reactivation of T cells that are “switched off” by tumor cells or by the tumor microenvironment. Even advanced metastatic disease, previously considered as untreatable, can benefit from cancer immunotherapy. However, still a good proportion of patients does not respond to therapy or acquires resistance during treatment. Some genera or species of bacteria have been associated with treatment response or toxicity, but as the composition of the microbiota is not static, rather, it is very dynamic there is promise that by changing the microbiota composition, or by harnessing the microbiota ‘secrete’ tricks, one can improve treatment efficacy or reduce toxicity. Several players, including diet, prebiotics, probiotics, and postbiotics, have been proposed to shape the microbiota. In this minireview, we summarize very recent data on how to train the microbiota to increase ICB efficacy and reduce toxicity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsMicrobiotaProbioticsHumansImmune Checkpoint InhibitorsImmunotherapyTumor Microenvironment

Stichwörter der Autor:innen

Cancer immunotherapyMetabolitesMicrobiotaPostbioticsToxicityTreatment efficacy

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • IRCSS Humanitas Research Hospital, Milan, Italy.
  • Department of Biomedical Sciences, Humanitas University, Milan, Italy.

ORCID-Profile: Maria Rescigno

Zitieren

APA

Rescigno, M. (2023). Training the microbiota to increase immune checkpoint blockade and to reduce toxicity. European Journal of Immunology. https://doi.org/10.1002/eji.202250183

Vancouver

Rescigno M. Training the microbiota to increase immune checkpoint blockade and to reduce toxicity. European Journal of Immunology. 2023. doi:10.1002/eji.202250183

BibTeX
@article{Rescigno2023,
  author = {Rescigno, Maria},
  title = {Training the microbiota to increase immune checkpoint blockade and to reduce toxicity},
  journal = {European Journal of Immunology},
  year = {2023},
  doi = {10.1002/eji.202250183}
}
Kostenlos starten →